View Author
patient database event method safety ofatumumab study response treatment incidence system infusion exposure health rituximab drug safety number dose groups group 2010 john wiley signal month trial drug safety monitoring blood grade lymphoma protopathic bias eu-adr figure record incidence rates table fi rst infusion leopard monitoring antibody gamma poisson shrinker prescription result pharmacoepidemiol drug saf performance detection fication nsaid association italy drug reactions erasmus mc estimate information ratio disease eu-adr project 10.1002/ volume country healthcare project therapy serum follow-up protopathic control duration population fi rst european university signi drug safety signals surveillance netherland j clin oncol pharmacoepidemiol period wiley research network reference
3 Most Recent Publications
|
Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods
(Article)
Schuemie, M.J. Coloma, P.M. Innocenti, F. Mazzaglia, G. Picelli, G. Scotti, L. Lei, J. van der Sturkenboom, M.C.J.M. Straatman, H. Herings, R.M.C. Trifiro, G. Matthews, J.N. Prieto-Merino, D. Molokhia, M. Pedersen, L.M. Gini, R. |
2012-10-01
|
|
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: The EU-ADR Project
(Article)
Coloma, P.M. Schuemie, M.J. Lei, J. van der Sturkenboom, M.C.J.M. Trifirò, G. Gini, R. Herings, R.M.C. Hippisley-Cox, J. Mazzaglia, G. Giaquinto, C. Corrao, G. Pedersen, L.M. |
2011-01-01
|
|
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: Results of a phase 1/2 trial
(Article)
Hagenbeek, A. Gadeberg, O. Kneba, M. Engert, A. Sonneveld, P. Flensburg, M. Petersen, J. Losic, N. Radford, J. Johnson, P. Pedersen, L.M. Walewski, J. Hellmann, A. Link, B.K. Robak, T. Wojtukiewicz, M. Pfreundschuh, M. |
2008-06-15
|
